William B. Horne - Feb 24, 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ William B. Horne
Stock symbol
ALZN
Transactions as of
Feb 24, 2023
Transactions value $
$2,000
Form type
4
Date filed
2/28/2023, 03:30 PM
Previous filing
Jan 11, 2023
Next filing
Feb 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Options Exercise $2K +500K +100% $0.00* 1M Feb 24, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Stock Options (Right to Buy) Options Exercise $0 -500K -25% $0.00 1.5M Feb 24, 2023 Common Stock 500K $0.00 Direct F2
holding ALZN Stock Options (Right to Buy) 250K Feb 24, 2023 Common Stock 250K $1.50 Direct F3
holding ALZN Stock Options (Right to Buy) 250K Feb 24, 2023 Common Stock 250K $1.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options.
F2 The stock options exercised in this transaction were fully vested and exercisable as of the transaction date.
F3 The stock options vest ratably over thirty-six (36) months beginning on the date of grant, and are fully vested.
F4 None of these performance-based stock options are vested or exercisable.